Nadela, Kriziah Mae O.
HRN: 09-08-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/27/2023
02/02/2023
ORAL
12 Ml
TID
Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes